Newborn Screening for Sickle Cell and Cystic Fibrosis in England
Author Information
Author(s): Hilda Parker, Nadeem Qureshi, Fiona Ulph, Joe Kai
Primary Institution: Division of Primary Care, University of Nottingham
Hypothesis
What are the current practices and policy challenges in communicating carrier status results from newborn screening for sickle cell disorders and cystic fibrosis in England?
Conclusion
There is significant variation in how carrier results are communicated, which raises concerns about equity and clinical governance.
Supporting Evidence
- Diverse methods for imparting carrier results were reported across different regions.
- Non-specialists were preferred for communicating results to minimize parental anxiety.
- Challenges included funding constraints and the need for clearer national guidance.
Takeaway
This study looked at how doctors tell parents if their babies are carriers of certain genetic conditions, and found that different areas do it in different ways.
Methodology
Thematic analysis of semi-structured interviews with Child Health Coordinators from all English Health Regions.
Potential Biases
Responses may reflect the biases of the interviewees based on their specific roles and experiences.
Limitations
The study may not capture perspectives beyond the interviewees' roles, such as those from antenatal screening or primary care.
Participant Demographics
Child Health Coordinators from all nine English health regions.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website